Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Susan Groshen

6PUBLICATIONS

38CO-AUTHORS

Radiation therapyCancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 23, 2025

Phase I Study of <sup>131</sup>I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

Thomas Cash, Araz Marachelian, Steven G DuBois

|Feb 01, 2023

Ethics and Clinical Research: Improving Transparency and Informed Consent in Phase I Oncology Trials.

Paul H Frankel, Susan Groshen, Jan H Beumer

|Aug 19, 2022

EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma.

Sarmad Sadeghi, David Quinn, Tanya Dorff

|Jul 16, 2021

Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.

Steven G DuBois, M Meaghan Granger, Susan Groshen

|Jun 26, 2019

Improvements to the Escalation with Overdose Control design and a comparison with the restricted Continual Reassessment Method.

Lingyun Ji, Juan Pablo Lewinger, Mark Krailo

|Aug 11, 2018

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma.

Steven G DuBois, Yael P Mosse, Elizabeth Fox

Pageof 1

Frequent Collaborators

3 joint publications

Brian Weiss

2 joint publications

Steven G DuBois

2 joint publications

John M Maris

2 joint publications

Julie R Park

2 joint publications

Susan L Cohn

2 joint publications

Shahab Asgharzadeh

2 joint publications

Navin Pinto

2 joint publications

Kelly C Goldsmith

2 joint publications

Katherine K Matthay

2 joint publications

Kieuhoa T Vo

Frequent Collaborators

3 joint publications

Brian Weiss

2 joint publications

Steven G DuBois

2 joint publications

John M Maris

2 joint publications

Julie R Park

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Working with Human Tissues for Translational Cancer Research

Working with Human Tissues for Translational Cancer Research

Published on : Nov 26, 2015

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Working with Human Tissues for Translational Cancer Research

Working with Human Tissues for Translational Cancer Research

Published on : Nov 26, 2015

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos